The major factors that drive the
Global Aneurysmal Subarachnoid Hemorrhage Market are rise in incidence of road
accidents leading to head injuries and rupture of cerebral aneurysm cases,
causing aneurysmal subarachnoid hemorrhage; improved healthcare infrastructure;
and growth in awareness about aneurysmal subarachnoid hemorrhage. However,
stringent regulatory regulations and high cost of aneurysmal subarachnoid
hemorrhage diagnosis products restrain the market growth. Furthermore,
technological advancement in healthcare sector and willingness to adopt
innovative products for emergency care are expected to provide numerous
opportunities for market growth in the future.
Aneurysmal subarachnoid
hemorrhage is a condition wherein a brain aneurysm ruptures, resulting in
bleeding into the subarachnoid space. In severe cases, bleeding may cause brain
damage leading to paralysis or coma and even death. The National Institutes of
Health (NIH) has stated that aneurysmal subarachnoid hemorrhage (SAH) is a
worldwide health burden and possesses high fatality and permanent disability
rates.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/4393
The key players operating in
this market are
·
Edge Therapeutics Inc.
·
Actelion Pharmaceuticals Ltd.
·
Arbor Pharmaceuticals Inc.
·
Mayfield Brain & Spine
·
Europa Group
·
GE Healthcare
·
Koninklijke Philips N.V.
·
Siemens AG
·
Trivitron Healthcare
·
Toshiba Medical Systems
Corporation
The global aneurysmal
subarachnoid hemorrhage market is segmented based on therapy type, end user,
and region. On the basis of therapy type, it is divided into computed
tomography (CT) scan, magnetic resonance imaging (MRI), lumbar puncture,
xanthochromia, cerebral angiography, and transcranial Doppler ultrasound. Based
on end user, it is categorized into hospitals, clinics, and others. Based on
region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/4393
Key Benefits
- The study
provides an in-depth analysis of the global aneurysmal subarachnoid
hemorrhage market with current trends and future estimations from 2016 to
2023 to elucidate the imminent investment pockets.
- Comprehensive
analysis of factors that drive and restrict the market growth is provided.
- Identification
of factors instrumental in changing the market scenario, rise in
opportunities, and identification of key companies that can influence this
market on a global and regional scale are provided.
- Key players
are profiled and their strategies are analyzed thoroughly to understand
the competitive outlook of the market.
Access Full Summery @ https://www.alliedmarketresearch.com/aneurysmal-subarachnoid-hemorrhage-market
No comments:
Post a Comment